Suppr超能文献

可溶性人结肠癌提取物的非特异性抑制活性:作用机制初探

Nonspecific inhibitory activity of soluble human colon carcinoma extracts: tentative mechanism of action.

作者信息

Pommier G J, Remacle-Bonnet M M, Rance R J, Depieds R C

出版信息

J Natl Cancer Inst. 1981 Oct;67(4):791-802.

PMID:6456370
Abstract

Soluble human colon carcinoma extract(s) (SCE) were potent nonspecific inhibitors of lymphoproliferative responses to mitogens. Inhibition was concomitant with induction in about 35% of cells of morphologic alterations for most of them comparable with the ones observed in mitogen-induced blast cells. Nonetheless, these blastlike cells did not proliferate. SCE did not interfere with mitogen binding to cell receptors. Moreover, SCE was unable to induce or activate suppressor cells, and its primary target cell was the unresponsive lymphoid cell itself. The inhibitory effect of SCE was early and irreversible. The differential activity of SCE can be correlated with an early [3H]uridine uptake, which was inhibited 6 hours later, as seen for the other biochemical parameters of cell activation. Also, SCE altered membrane-bound ATPase activities. Na,K-ATPase was strongly inhibited, whereas Ca2+-dependent and Mg2+-dependent ATPases were stimulated. These observations were discussed as an SCE-lymphocyte plasma membrane interaction translated into differential signals to the intracellular metabolic pathways.

摘要

可溶性人结肠癌提取物(SCE)是对丝裂原诱导的淋巴细胞增殖反应有效的非特异性抑制剂。抑制作用伴随着约35%的细胞出现形态学改变,其中大多数改变与丝裂原诱导的母细胞中观察到的改变相当。然而,这些母细胞样细胞并不增殖。SCE不干扰丝裂原与细胞受体的结合。此外,SCE不能诱导或激活抑制性细胞,其主要靶细胞是无反应性的淋巴细胞本身。SCE的抑制作用出现早且不可逆。SCE的差异活性可能与早期[3H]尿苷摄取有关,6小时后这种摄取受到抑制,这与细胞激活的其他生化参数情况相同。而且,SCE改变了膜结合ATP酶的活性。钠钾ATP酶受到强烈抑制,而钙依赖性和镁依赖性ATP酶则被激活。这些观察结果被认为是SCE与淋巴细胞质膜相互作用转化为细胞内代谢途径的差异信号。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验